Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

Risk factors for osteoporosis, with Jim Squires revealing his shock diagnosis aged 27 after taking steroids for arthritis and ...

VAIL, CO USA (UroToday.com) - Background: Two oral agents have recently been approved for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC): abiraterone acetate ...

Alan Knight delivered an encouraging update on his ongoing cancer battle and insisted: I feel okay. In September, the Blues ...

Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic variantsSUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe ...

NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...

Ahead of World Cancer Day, we hear from celebrities who have spoken about how a cancer diagnosis can lead to positive life changes.

As our TV columnist recovers from cancer operations, she focuses on two new limited series about women who claimed to have ...

Dave Coulier has been open about his battle with cancer since he went public with his diagnosis in November 2024 ...

KYZATREX is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX is safe or effective in males younger than 18 years old. Improper use may affect bone growth in ...